China Universal Asset Management Co., Ltd. Immunocore Holdings PLC Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 6,621 shares of IMCR stock, worth $244,778. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,621
Previous 6,621
-0.0%
Holding current value
$244,778
Previous $430,000
-0.0%
% of portfolio
0.06%
Previous 0.05%
Shares
11 transactions
Others Institutions Holding IMCR
# of Institutions
163Shares Held
37.8MCall Options Held
540KPut Options Held
97.3K-
Rtw Investments, LP New York, NY6.02MShares$223 Million6.28% of portfolio
-
Wellington Management Group LLP Boston, MA5.75MShares$212 Million0.07% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.44MShares$90.1 Million0.02% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.37MShares$87.5 Million4.02% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY1.79MShares$66.1 Million4.36% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.62B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...